PROVIDER PROFILE · NPI 1679572978

Miriam LibkindM.D.

DermatologyWoodmere, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,106

Unique beneficiaries

—

Total services

1,912

Distinct HCPCS

Medicare payment

$118K

Peer benchmark

Total Medicare services vs. 960 Dermatology providers in NY — above median (cohort median 1,575).

PRESCRIBING · PART D · 2024

Total Rx claims

580

Beneficiaries

—

Total drug cost

$10K

Distinct drugs

Brand share

14.5%

Top prescribed drugs

Triamcinolone Acetonide79 claims

Mometasone Furoate71 claims

Ketoconazole56 claims

Hydrocortisone42 claims

Clindamycin Phosphate39 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

100.0

Cost

0.0

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$198

Payment records

By payment type

Education$198

REFERRAL NETWORK

Where Miriam Libkind's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Debra Skopicki Dermatology · Woodmere, NY	76	172
Ira Pion Dermatology · Woodmere, NY	26	203
Northwell Health Laboratories Clinical Laboratory · New Hyde Park, NY	26	67
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Melville, NY	21	49
Ameripath New York Llc Clinical Laboratory · White Plains, NY	15	33

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history